Skip to main content

Marina Ortiz Palacios

I am a paediatric oncologist and since 2022 I have been working in Paediatric Oncohaematology at the Vall d'Hebron University Hospital. My clinical and research activity focuses on the diagnosis, treatment and follow-up of paediatric solid tumours.

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Doctor
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital
Marina Ortiz Palacios

Marina Ortiz Palacios

Marina Ortiz Palacios

Institutions of which they are part

Predoctoral researcher
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca
Doctor
Paediatric Oncology and Haematology
Children's Hospital and Woman's Hospital

I am a paediatric oncologist and since 2022 I have been working in Paediatric Oncohaematology at the Vall d'Hebron University Hospital. My clinical and research activity focuses on the diagnosis, treatment and follow-up of paediatric solid tumours.

I studied Medicine and Surgery at the Faculty of Medicine in Albacete (University of Castilla-La Mancha), followed by a specialisation in Paediatrics and its Specific Areas at the Virgen de la Arrixaca University Clinical Hospital in Murcia (HCUVA). I then completed a Master's degree in Paediatric Oncology and Haematology at UNIR. I then completed a fellowship in Paediatric Oncology and Haematology at the Vall d'Hebron University Hospital (HUVH) in Barcelona. I then joined the paediatric oncology department as an assistant.

Related news

The European initiative Hope4Kids will strengthen and harmonise paediatric palliative care across Europe, with the aim of ensuring comprehensive, high-quality care for all children living with life-threatening or life-limiting conditions.

The initiative will enable young people aged 12 to 18 to collaborate with campus researchers in the design, development and communication of scientific projects, placing patients and families at the centre of the research process.

The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.

Related professionals

Tomás Van Eeckhout Carter

Tomás Van Eeckhout Carter

Administration and Management
Donation and transplantation of organs, tissues and cells
Read more
Francina Munell Casadesus

Francina Munell Casadesus

Main researcher
Pediatric Neurology
Read more
Cristina Hernández Pascual

Cristina Hernández Pascual

Main researcher
Diabetes and Metabolism
Read more
Xavier Martínez Gómez

Xavier Martínez Gómez

Predoctoral researcher
Epidemiology and Public Health
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.